4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
TelyRx Holdings Inc. (TELY) operates in the Pharmaceutical Retailers industry and is headquartered in Clearwater, United States. Its market capitalization is roughly $69 million. In the fiscal year ended 2025-12-31, TELY reported $43M in revenue and ($5M) in net income.
TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Revenue | $43M | $10M | $0M |
| Gross Profit | $23M | $4M | $0M |
| Operating Income (EBIT) | ($5M) | ($4M) | ($1M) |
| Net Income | ($5M) | ($14M) | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $19M | $14M | $12M | $7M | $5M |
| Gross Profit | $11M | $8M | $7M | $4M | $2M |
| Operating Income (EBIT) | ($3M) | ($3M) | ($1M) | $0M | ($1M) |
| Net Income | ($5M) | ($3M) | ($1M) | $0M | ($1M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Assets | $10M | $8M | $12M |
| Total Liabilities | $18M | $11M | $14M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TELY viewer.
About TickerBase · Data methodology & sources · Privacy · Terms